piracetam has been researched along with Autoimmune Diabetes in 3 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reda, HM | 1 |
| Zaitone, SA | 1 |
| Moustafa, YM | 1 |
| Baratsevich, ER | 1 |
| Posokhina, OV | 1 |
| Zesiewicz, TA | 1 |
| Pathak, A | 1 |
| Sullivan, KL | 1 |
| Shamayev, M | 1 |
| Hauser, RA | 1 |
3 other studies available for piracetam and Autoimmune Diabetes
| Article | Year |
|---|---|
Effect of levetiracetam versus gabapentin on peripheral neuropathy and sciatic degeneration in streptozotocin-diabetic mice: Influence on spinal microglia and astrocytes.
Topics: Amines; Animals; Astrocytes; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Experimental; Diabetes | 2016 |
[Approaches to the therapy of neurological presentations in diabetes mellitus].
Topics: Adult; Aged; Antioxidants; Cognition Disorders; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2 | 2010 |
Treatment of chorea with levetiracetam.
Topics: Acute Disease; Adult; Anticonvulsants; Chorea; Diabetes Mellitus, Type 1; Female; Humans; Levetirace | 2006 |